| 000 | 01252 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250514072112.0 | ||
| 264 | 0 | _c20040412 | |
| 008 | 200404s 0 0 eng d | ||
| 022 | _a0012-186X | ||
| 024 | 7 |
_a10.1007/s00125-003-1134-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRotondi, M | |
| 245 | 0 | 0 |
_a-to: Nicoletti F, Conget L, Di Mauro M et al. (2002) Serum concentrations of the interferon-alpha-inducible chemokine IP-10/CXCL10 are augmented in both newly-diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45:1107-1110. _h[electronic resource] |
| 260 |
_bDiabetologia _cJul 2003 |
||
| 300 |
_a1020-1 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAutoantibodies _xblood |
| 650 | 0 | 4 | _aChemokine CXCL10 |
| 650 | 0 | 4 |
_aChemokines, CXC _xblood |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-gamma _xblood |
| 700 | 1 | _aRomagnani, P | |
| 700 | 1 | _aBrozzetti, A | |
| 700 | 1 | _aSanteusanio, F | |
| 700 | 1 | _aSerio, M | |
| 700 | 1 | _aFalorni, A | |
| 773 | 0 |
_tDiabetologia _gvol. 46 _gno. 7 _gp. 1020-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00125-003-1134-4 _zAvailable from publisher's website |
| 999 |
_c12603262 _d12603262 |
||